ARVN:NAS (USA)

Arvinas Inc

$ 22.7 0 (0%)
Volume: 102,030 Avg Vol (1m): 133,071
Market Cap $: 733.81 Mil Enterprise Value $: 548.12 Mil
P/E (TTM): 0.00 P/B: 5.18
Earnings Power Value 0
Net Current Asset Value 4.26
Tangible Book 4.38
Projected FCF 0
Median P/S Value 16.76
Graham Number 0
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
YTD (-%)

Financial Strength : 7/10

Current vs industry vs history
Cash-to-Debt 87.20
Equity-to-Asset 0.69
Debt-to-Equity 0.02
Debt-to-EBITDA -0.05
Altman Z-Score 5.31
DISTRESS
GREY
SAFE

Profitability & Growth : 2/10

Current vs industry vs history
Operating Margin % -305.82
Net Margin % -289.61
ROE % -352.92
ROA % -44.03
ROC (Joel Greenblatt) % -1142.45

» ARVN's 30-Y Financials

Financials (Next Earnings Date: 2019-06-26 Est.)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NAS:ARVN

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Biotechnology » Biotechnology    NAICS : 325412    SIC : 2834
Compare
Traded in other countries
Address 395 Winchester Avenue, 5 Science Park, New Haven, CT, USA, 06511

Ratios

Current vs industry vs history
PB Ratio 5.18
PS Ratio 11.19
EV-to-EBIT -13.22
EV-to-EBITDA -13.43
EV-to-Revenue 38.19
Current Ratio 8.52
Quick Ratio 8.52
Days Sales Outstanding 70.74

Dividend & Buy Back

Current vs industry vs history

Valuation & Return

Current vs industry vs history
Price-to-Tangible-Book 5.18
Price-to-Median-PS-Value 1.35
Earnings Yield (Joel Greenblatt) % -7.57

More Statistics

Revenue (TTM) (Mil) $ 14.32
EPS (TTM) $ -64.21
Beta 0
Volatility % 0
52-Week Range $ 10.19 - 25.61
Shares Outstanding (Mil) 32.33

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 0
Positive ROA N
Positive CFROA N
Higher ROA yoy N
CFROA > ROA N
Lower Leverage yoy N
Higher Current Ratio yoy N
Less Shares Outstanding yoy N
Higher Gross Margin yoy N
Higher Asset Turnover yoy N